Epidemiological implications of HIV-hepatitis C co-infection in South and Southeast Asia

Current HIV/AIDS Reports

Volumn 11, Issue 2, 2014, Pages 128-133

  Ye, Shaodong ^a   Pang, Lin ^a   Wang, Xiaochun ^a   Liu, Zhongfu ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Blood donor; Global epidemic; Hepatitis C; HIV; HIV HCV Co infection; HIV positive; Injection drug use; Prevalence; Risk factors; South and Southeast Asia; South Asia; Southeast Asia

Indexed keywords

AFGHANISTAN; BANGLADESH; BHUTAN; BLOOD DONOR; BRUNEI DARUSSALAM; CAMBODIA; DISEASE ASSOCIATION; DRUG USE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDONESIA; LAOS; MALAYSIA; MALDIVES; MIXED INFECTION; MYANMAR; NEPAL; PAKISTAN; PHILIPPINES; PREVALENCE; PREVENTION AND CONTROL; REVIEW; RISK FACTOR; SINGAPORE; SRI LANKA; THAILAND; TIMOR-LESTE; VIET NAM; COINFECTION; COMORBIDITY; EPIDEMIOLOGY; HEALTH; HIV INFECTIONS; SOUTHEAST ASIA; STATISTICS AND NUMERICAL DATA; TRENDS;

ASIA, SOUTHEASTERN; COINFECTION; COMORBIDITY; DRUG USERS; GLOBAL HEALTH; HEPATITIS C; HIV INFECTIONS; HUMANS; PREVALENCE; RISK FACTORS;

EID: 84903644638     PISSN: 15483568     EISSN: 15483576     Source Type: Journal    
DOI: 10.1007/s11904-014-0206-z     Document Type: Review

References (36)

1. • World Health Organization. Hepatitis C Fact Sheets. July 2013. Available from: http://www.who.int/mediacentre/factsheets/fs164/en/. This HCV fact sheets provided updated HCV epidemics world widely.
2. • Joint United Nations Programme on HIV/AIDS. 2013 UNAIDS Report on the global AIDS epidemic. December 2013. Available from: http://www.unaids.org/ en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/ UNAIDS-Global-Report-2013-en.pdf. This report provided updated HIV epidemics world widely.
3. Barth RE, Huijgen Q, Taljaard J, et al. Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis. Int J Infect Dis. 2010;14(12):e1024-31.
4. Zhuang X, Liang Y, Chow EP, et al. HIV and HCV prevalence among entrants to methadone maintenance treatment clinics in China: a systematic review and meta-analysis. BMC Infect Dis. 2012;12:130.
5. Maier I, Wu GY. Hepatitis C and HIV co-infection: a review. World J Gastroenterol. 2002;8(4):577-9. (Pubitemid 34918644)
6. Danta M, Dusheiko GM. Acute HCV in HIV-positive individuals - a review. Curr Pharm Des. 2008;14(17):1690-7. (Pubitemid 351998594)
7. Kontorinis N, Agarwal K, Dieterich DT. Treatment of hepatitis C virus in HIV patients: a review. AIDS. 2005;19 Suppl 3:S166-73. (Pubitemid 41682184)
8. •• Shrestha AC, Ghimire P, Tiwari BR, et al. Co-infection rate of HIV, HBV and Syphilis among HCV seropositive identified blood donors in Kathmandu, Nepal. Infect Ecol Epidemiol. 2012;2. This study was conducted among 139 HCV seropositive blood donors and the HIV-HCV co-infection rate was 5.75%.
9. Operskalski EA, Kovacs A. HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies. Curr HIV/AIDS Rep. 2011;8(1):12-22.
10. Sulkowski MS. HCV therapy in HIV-infected patients. Liver Int. 2013;33 Suppl 1:63-7.
11. Agdamag DM, Kageyama S, Alesna ET, et al. Rapid spread of hepatitis C virus among injecting-drug users in the Philippines: implications for HIV epidemics. J Med Virol. 2005;77(2):221-6. (Pubitemid 41285790)
12. Zhao L, Feng Y, Xia XS. The different epidemic and evolution of HCV genotypes. Yi Chuan. 2012;34(6):666-72.
13. Law WP, Duncombe CJ, Mahanontharit A, et al. Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort. AIDS. 2004;18(8):1169-77. (Pubitemid 38738516)
14. Saravanan S, Velu V, Kumarasamy N, et al. Coinfection of hepatitis B and hepatitis C virus in HIV-infected patients in south India. World J Gastroenterol. 2007;13(37):5015-20. (Pubitemid 47496836)
15. Ponamgi SP, Rahamathulla S, Kumar YN, et al. Prevalence of hepatitis C virus (HCV) coinfection in HIV infected individuals in south India and characterization of HCV genotypes. Indian J Med Microbiol. 2009;27(1):12-6.
16. •• Nagmoti MB, Patil CS, Jyoti MN, et al. Prevalence of hepatitis C infection in HIV-seropositive individuals in and around Belgaum, south India. Int J STD AIDS. 2012;23(10):e14-5. This study was conducted among 16,124 serum samples from suspected patients and the HIV-HCV co-infection rate was 3.52%.
17. •• Zaw SK, Tun ST, Thida A, et al. Prevalence of hepatitis C and B virus among patients infected with HIV: a cross-sectional analysis of a large HIV care programme in Myanmar. Trop Doct. 2013;43(3):113-5. This study was conducted among 11,032 HIV-infected patients and the HIV-HCV co-infection rate was 5.3%.
18. •• Anggorowati N, Yano Y, Heriyanto DS, et al. Clinical and virological characteristics of hepatitis B or C virus co-infection with HIVin Indonesian patients. J Med Virol. 2012;84(6):857-65. This study was conducted among 126 HIV patients and the HIV-HCV coinfection rate was 34.1%.
19. Ocama P, Seremba E. Management of HIV and hepatitis C virus infections in resource-limited settings. Curr Opin HIV AIDS. 2011;6(6):539-45.
20. Matthews GV, Dore GJ. HIV and hepatitis C coinfection. J Gastroenterol Hepatol. 2008;23(7 Pt 1):1000-8. (Pubitemid 352019390)
21. •• Barnawal SP, Niraula SR, Agrahari AK et al. Human immunodeficiency virus and hepatitis C virus coinfection in Nepal. Indian J Gastroenterol. 2013. This study was conducted among 313 HIV patients and the HIV-HCV co-infection rate was 42%.
22. •• Dunford L, Carr MJ, Dean J, et al. A multicentre molecular analysis of hepatitis B and blood-borne virus coinfections in Viet Nam. PLoS One. 2012;7(6):e39027. This study was conducted among 8654 high risk individuals. 89.8% HCV of the HBV-HIV co-infected IDUs and 40% HCV of HBV-HIV co-infected CSWs were found.
23. •• Goyet S, Lerolle N, Fournier-Nicolle I, et al. Risk factors for hepatitis C transmission in HIV patients, Hepacam Study, ANRS 12267 Cambodia. AIDS Behav. 2013. This case-control study had 44 HCV/HIV co-infected patients and 160 HIV mono-infected patients without HCV antibodies, the risk factors associated with co-infection included age older than 50 years, the exposure to multiple parenteral infusions before the year 2000, surgery and fibroscopy.
24. •• Poudel KC, Palmer PH, Jimba M, et al. Coinfection of Hepatitis C Virus among HIV-Positive People in the Kathmandu Valley, Nepal. J Int Assoc Provid AIDS Care. 2013. This study was conducted among 319 HIV-positive and the HIV-HCV co-infection rate was 43.3%.
25. •• Praseeda SD, Anuradha D, Jayanthi SS. A study on the HBV and the HCV infections in female sex workers and their co-infection with HIV. J Clin Diagn Res. 2013;7(2):234-7. This study was conducted among 250 CSWs and the HIV-HCV co-infection rate was 1.2%.
26. •• Prasetyo AA, Dirgahayu P, Sari Y, et al. Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia. J Infect Dev Ctries. 2013;7(6):453-67. This study was conducted among 375 drug abuser inmates and the HIV-HCV co-infection rate was 4%.
27. •• Sereno L, Mesquita F, Kato M, et al. Epidemiology, responses, and way forward: the silent epidemic of viral hepatitis and HIV coinfection in Vietnam. J Int Assoc Physicians AIDS Care (Chic). 2012;11(5):311-20. This study reviewed data of HIV in Vietnam and the HIV-HCV co-infection rate reached 98.5% among HIV infected drug users.
28. •• Than NN, Sungkanuparph S, Maek-A-Nantawat W, et al. Comparison of clinical outcomes between HIV-infected patients with and without HCV co-infection in a resourcelimited setting. Southeast Asian J Trop Med Public Health. 2012;43(3):646-51. This retrospective cohort study had 57 HIV-infected patients with HCV and 114 HIV-infected patients without HCV. It found that HCV co-infection did not appear to affect HIV morbidity, mortality or treatment responses to ART.
29. •• Tsuchiya N, Pathipvanich P, Rojanawiwat A, et al. Chronic hepatitis B and C co-infection increased all-cause mortality in HAART-naive HIV patients in Northern Thailand. Epidemiol Infect. 2013;141(9):1840-8. This study was conducted among 700 HAART-naive HIV-infected patients and the HIV-HCV co-infection rate was 3.3%.
30. Vivithanaporn P, Nelles K, DeBlock L, et al. Hepatitis C virus coinfection increases neurocognitive impairment severity and risk of death in treated HIV/AIDS. J Neurol Sci. 2012;312(1-2):45-51.
31. Salmon-Ceron D, Lewden C, Morlat P, et al. Liver disease as a major cause of death among HIVinfected patients: role of hepatitis C and B viruses and alcohol. J Hepatol. 2005;42(6):799-805. (Pubitemid 40693195)
32. Rockstroh JK, Peters L, Grint D, et al. Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV? J Hepatol. 2013;59(2):213-20.
33. Ragni MV, Nalesnik MA, Schillo R, Dang Q. Highly active antiretroviral therapy improves ESLD-free survival in HIV-HCV coinfection. Haemophilia. 2009;15(2):552-8.
34. Szaflik J, Bełzecka-Majszyk A. Patients with HBV, HCVand HIV antigens-medical management, surgical procedures, equipment sterilization principles. Klin Oczna. 2003;105(6):448-52.
35. Ouzan D. Risk of transmission of hepatitis C through endoscopy of the digestive tract. Presse Med. 1999;28(20):1091-4. (Pubitemid 29277402)
36. Santana JL, Rodríguez-Medina JR, Rodríguez-Orengo JF. Clinical challenges and controversies in the management of HIV/ HCV-coinfected individuals. P R Health Sci J. 2004;23(2 Suppl):35-40.